# Effects of the Use of Adjuvant Drugs After Extracorporeal Shockwave Lithotripsy (ESWL) in Renal Calculus

> **NCT01215708** · PHASE3 · UNKNOWN · sponsor: **University of Sao Paulo General Hospital** · enrollment: 136 (actual)

## Conditions studied

- Renal Calculi

## Interventions

- **DRUG:** Tamsulosin

## Key facts

- **NCT ID:** NCT01215708
- **Lead sponsor:** University of Sao Paulo General Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2006-08
- **Primary completion:** 2010-06
- **Final completion:** 2010-12
- **Target enrollment:** 136 (ACTUAL)
- **Last updated:** 2010-10-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01215708

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01215708, "Effects of the Use of Adjuvant Drugs After Extracorporeal Shockwave Lithotripsy (ESWL) in Renal Calculus". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01215708. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*